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The transcription factor Pax5 represses B
lineage-inappropriate genes and activates B
cell-specific genes in B lymphocytes. Here we
have identified 170 Pax5-activated genes. Con-
ditional mutagenesis demonstrated that the
Pax5-regulated genes require continuous
Pax5 activity for normal expression in pro-B
and mature B cells. Expression of half of the
Pax5-activated genes is either absent or sub-
stantially reduced upon Pax5 loss in plasma
cells. Direct Pax5 target genes were identified
based on their protein synthesis-independent
activation by a Pax5-estrogen receptor fusion
protein. Chromatin immunoprecipitation (ChIP)
of Pax5 together with chromatin profiling
by ChIP-on-chip analysis demonstrated that
Pax5 directly activates the chromatin at pro-
moters or putative enhancers of Pax5 target
genes. The Pax5-activated genes code for key
regulatory and structural proteins involved in
B cell signaling, adhesion, migration, antigen
presentation, and germinal-center B cell forma-
tion, thus revealing a complex regulatory net-
work that is activated by Pax5 to control B cell
development and function.
INTRODUCTION
A multitude of transcriptional regulators control the entry
of lymphoid progenitors into the B cell lineage and the
subsequent developmental progression to terminally dif-
ferentiated plasma cells. One of the first transcription
factors to be expressed in early B cell development is
Pax5 (also known as B cell-specific activator protein
[BSAP]), which is exclusively transcribed in the B lymphoid
lineage of the hematopoietic system (Fuxa and Busslinger,
2007). Pax5 is essential for B lymphopoiesis, because its
mutation leads to an arrest at an early progenitor B cellstage in the bone marrow (Nutt et al., 1997). Pax5/
pro-B cells correspond to uncommitted lymphoid progen-
itors with a latent myeloid differentiation potential (Nutt
et al., 1999; Cobaleda et al., 2007). The restoration of
Pax5 expression suppresses the multilineage potential of
Pax5/ pro-B cells, while simultaneously promoting their
development to mature B cells (Nutt et al., 1999). Con-
versely, the loss of Pax5 expression by conditional gene
inactivation converts committed pro-B cells into lymphoid
progenitors with a broad developmental potential (Mikkola
et al., 2002). These data identify Pax5 as the critical B cell
commitment factor, which is required throughout B lym-
phopoiesis to maintain the identity and function of
B cells (Horcher et al., 2001).
At the molecular level, Pax5 fulfills its commitment func-
tion by repressing B lineage-inappropriate genes and
simultaneously activating B cell-specific genes (Cobaleda
et al., 2007). The transcriptional activity of Pax5 at a given
gene is determined in a context-dependent manner by
adjacent transcription factors, which cooperate with
Pax5 in recruiting either Groucho corepressors or his-
tone-acetylating coactivators to regulatory elements
(Cobaleda et al., 2007). We have recently studied the re-
pression function of Pax5 by identifying 110 Pax5-re-
pressed genes that code for a plethora of proteins involved
in cell-cell communication, adhesion, migration, nuclear
processes, and cellular metabolism (Delogu et al., 2006).
Most conspicuously, Pax5 downregulates the expression
of many cell-surface receptors and intracellular trans-
ducers that mediate signaling in early progenitors and/or
cells of different hematopoietic lineages. As a conse-
quence, Pax5 shuts down inappropriate signaling systems
at B lineage commitment (Cobaleda et al., 2007). Interest-
ingly, the lineage-inappropriate genes require continuous
Pax5 activity for their repression from pro-B to mature B
cells, but are then reactivated in plasma cells. Hence, the
physiological loss of Pax5 during terminal differentiation
contributes to the plasma cell transcription program
(Delogu et al., 2006).
The identification of a few activated Pax5 target genes
by candidate gene approach revealed an essential role
for the Pax5 activation function in controlling signal trans-
duction from the pre-BCR and BCR, which constituteImmunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 49
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Pax5-Dependent Gene Activation in B Cellsimportant checkpoints in B cell development. Pax5 facili-
tates expression of the immunoglobulin heavy chain by
promoting VH-DJH recombination at the IgH locus in pro-
B cells (Nutt et al., 1997; Fuxa et al., 2004). In addition,
Pax5 directly activates target genes coding for essential
components of (pre)BCR signaling such as the signal-
transducing chain Iga (CD79a, mb1; Fitzsimmons et al.,
1996; Nutt et al., 1997), the costimulatory receptor CD19
(Kozmik et al., 1992; Nutt et al., 1998), and the central
adaptor protein BLNK (SLP-65) (Schebesta et al., 2002).
Pax5 furthermore contributes to the regulatory network
by activating the transcription factor gene Lef1 in pro-B
cells (Nutt et al., 1998) and by maintaining Ebf1 expression
in committed B lymphocytes (Fuxa et al., 2004; Nera et al.,
2006; Roessler et al., 2007).
To systematically study the activation function of Pax5,
we have now identified 170 Pax5-activated genes by
gene-expression profiling of wild-type and Pax5/ pro-
B cells. Detailed investigation of the Pax5-activated genes
by expression analyses, conditional Pax5 mutagenesis,
and ChIP-on-chip chromatin profiling has provided impor-
tant insight into how Pax5 controls the development and
function of B cells at the molecular level.
RESULTS
Pax5-Dependent Gene Activation in Pro-B Cells
While screening for Pax5-repressed genes, we recently
estimated that Pax5 represses 44% and activates 56%
of the genes, which are differentially expressed in
Pax5+/+ and Pax5/ pro-B cells (Delogu et al., 2006).
Here we describe the identification and characterization
of those genes, which are activated by Pax5 at B cell com-
mitment. For microarray screening, we used a mouse
‘‘lymphochip’’ (Shaffer et al., 2004) and a second cDNA
microarray containing unselected mouse ESTs, which
together corresponded to 18,000 different UniGene
clusters. These cDNA microarrays were hybridized with
Cy3- and Cy5-labeled probes prepared from short-term
cultured or ex vivo sortedPax5+/+ andPax5/ pro-B cells,
respectively (Figure S1 in the Supplemental Data available
online). Six hybridizations were performed with two inde-
pendent RNA preparations of the following cell pairs: cul-
tured Pax5+/+ versus Pax5/ (23), cultured Pax5+/+
Rag2/ versus Pax5/ Rag2/ (23), and ex vivo sorted
Pax5+/+ versus Pax5/ (23) pro-B cells. cDNA clones
with a Cy3/Cy5 fluorescence ratio of R2 in all hybridiza-
tions were selected as activated genes for further evalua-
tion. Redundancy strengthened the reliability of the
hybridization data, as shown by the fact that most genes
were represented by several cDNA clones on the different
microarrays. Our stringent evaluation of the microarray
data proved to be appropriate for identifying the previ-
ously described Pax5 target genes Cd19, Blnk, Cd79a
(Iga, mb1), Lef1, Ebf1, and Bcl2l1 (Bcl-x) (Cobaleda
et al., 2007; Table S3).
In addition to these known genes, our cDNA microarray
analysis identified another 170 Pax5-activated genes
(Table S3). These genes code for proteins belonging to50 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.the following functional classes: 3 secreted proteins, 29
cell-surface receptors or adhesion proteins, 19 intracellu-
lar signal transducers, 23 transcription factors or nuclear
proteins, 8 cell-cycle regulators, 6 proteins involved in
protein turnover, 8 regulators of protein trafficking and
secretion, 7 cytoskeleton-associated molecules, 25 meta-
bolic enzymes, 6 transporters or channels, 7 proteins with
other known functions, and 29 proteins of currently
unknown function (Table S3). The expression of 66 genes
was validated by semiquantitative RT-PCR analysis of
in vitro cultured Pax5+/+ and Pax5/ pro-B cells
(Figure 1A). The functions of the validated genes are sum-
marized in Table S4. A majority (35) of these genes was
activated at least 25-fold by Pax5 (Figure 1A). Several
genes were even entirely dependent on Pax5 for their
expression in cultured pro-B cells similar to the known
Pax5 target genes Cd19 and Blnk (Figure 1A). The gene
class characterized by a 5- to 25-fold activation ratio
contained many transcription factor genes, suggesting
that they are already expressed at a low basal amount in
lymphoid progenitors (Figure 1A). RT-PCR analysis of
ex vivo sorted Pax5+/+ and Pax5/ pro-B cells confirmed
the Pax5 dependency of the identified genes (Figure S2).
The expression of the Pax5-activated genes Enpep,
Bst1, Cd55, Cd97, and Sdc4 could be verified by flow
cytometric analysis, demonstrating an increase of the
respective cell-surface proteins on wild-type pro-B cells
compared to Pax5/ pro-B cells (Figure 1B). Together,
these experiments identified a multitude of Pax5-
activated genes that point to new functions of Pax5 in
the regulation of different aspects of B lymphopoiesis.
Loss of Gene Expression upon Pax5 Inactivation
in Committed Pro-B Cells
We next studied the Pax5 dependency of the newly iden-
tified genes by conditional Pax5 inactivation in CreED-30
Pax5fl/fl pro-B cells expressing a Cre-estrogen receptor
(ER) fusion protein (Mikkola et al., 2002). In this induction
system, the floxed (fl) exon 2 of Pax5 is efficiently deleted
upon Cre-ER activation, leading to a shift from the func-
tional full-length Pax5 mRNA (FL) to the exon 2-truncated
transcript (DE2) within 1 day of 4-hydroxytamoxifen (OHT)
treatment (Figure 2; controls). The Pax5 protein was
reduced to low amounts from day 2 to day 4 (Mikkola
et al., 2002), when expression of the control Cd19 and
Blnk transcripts started to decline (Figure 2). Interestingly,
the expression of the newly identified genes was down-
regulated in these pro-B cells with similar kinetics
(Figure 2) as the direct Pax5 target genes Cd19 and Blnk
(Kozmik et al., 1992; Nutt et al., 1998; Schebesta et al.,
2002). The expression of Fcrl1, Arnt1, and the Igko germ-
line transcript (GLT) declined even faster than Cd19 and
Blnk mRNA expression, possibly reflecting a very short
mRNA half-life or a more stringent dependency of their
transcription on the Pax5 protein dosage (Figure 2).
Finally, the observation that all Pax5-activated genes
were transcriptionally downregulated in the same pro-B
cells after conditional Pax5 inactivation provided indepen-
dent evidence for the Pax5-dependent regulation of these
Immunity
Pax5-Dependent Gene Activation in B CellsFigure 1. Gene Activation by Pax5 at the Pro-B Cell Stage
(A) RT-PCR analysis. Differential expression of the indicated genes was validated by RT-PCR analysis of 5-fold serial dilutions of cDNA prepared from
Pax5+/+ and Pax5/ pro-B cells, which were cultured in vitro for maximally 3 weeks. The cDNA input was normalized for equal levels of Hprt mRNA,
and the expression of known activated (Cd19, Blnk, Cd79a, Lef1) and repressed (Igj) Pax5 target genes is shown for comparison. The results are
representative of two pro-B cell pairs analyzed. The annotations, alternative names, and functions of the Pax5-activated genes (referred to by their
Gene names) are provided in Tables S3 and S4. Igk transcription was analyzed by detecting the spliced ko germline transcript (GLT).
(B) Flow cytometric analysis of the indicated cell-surface proteins on cultured Pax5+/+ (black line) and Pax5/ (dashed line) pro-B cells.genes (Figure 2). Hence, Pax5 is continuously required to
maintain normal transcription of the newly identified Pax5-
activated genes in committed pro-B cells.
Expression of Pax5-Activated Genes in Different
Hematopoietic Lineages
Pax5 is exclusively transcribed in the B lymphoid lineage
of the hematopoietic system (Fuxa and Busslinger,
2007), so we were interested to see whether some of thePax5-activated genes are similarly expressed only during
B cell development. To test this hypothesis, we analyzed
the expression of 32 Pax5-activated genes by RT-PCR
in erythroblasts, thymocytes, myeloid cells, pro-B, pre-
B, immature B, and mature B cells, which were isolated
as highly purified cell populations by FACS sorting
(Figure S3). As expected, 15 of these genes were predom-
inantly expressed within the B lymphoid lineage similar to
Cd19 and Blnk (Figure 3). The remaining 17 genes showedImmunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 51
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Pax5-Dependent Gene Activation in B CellsFigure 2. Loss of Activated Gene Expression upon Pax5 Deletion in Committed Pro-B Cells
Transcripts of the indicated genes were analyzed by RT-PCR at different days after 4-hydroxytamoxifen (OHT) treatment of pro-B cells, which were
established by short-term culture from the bone marrow ofCreED-30 Pax5fl/fl mice. PCR products corresponding to the full-length (FL) Pax5mRNA or
truncated Pax5 transcript lacking exon 2 (DE2) are indicated.mixed lineage expression patterns: they were expressed
in T and B cells (7), myeloid and B cells (4), myeloid, T,
and B cells (3), or erythroid and B cells together with other
cell types (3) (Figure 3). The expression of these genes in
non-B cells must therefore be regulated by other hemato-
poietic transcription factors, which substitute for Pax5
acting in the B cell lineage. The B lymphoid genes could
be further subdivided according to their expression at
different stages of B cell development. Half of these genes
(group I) were expressed, like Cd19 and Blnk, throughout
B lymphopoiesis from the pro-B cell to the mature B cell
stage (Figure 3). The second half of the B lymphoid genes
(group II) were predominantly expressed in pro-B and pre-
B cells (Figure 3), suggesting that their expression is
downregulated in immature and mature B cells because
of the presence of specific repressors or the absence of
activators cooperating with Pax5. The fact that all Pax5-52 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.activated genes were expressed during B cell develop-
ment further supports a role for Pax5 in the regulation of
these genes.
Downregulation of Activated Genes upon Pax5 Loss
in Late B Lymphopoiesis
We next investigated by conditional mutagenesis whether
the genes, which are activated by Pax5 in pro-B cells, are
still dependent on Pax5 for their expression in mature B
cells. The Cd19-cre line is ideal for this purpose, because
it efficiently deletes the floxed Pax5 allele only in mature B
cells leading to upregulation of CD25 (Horcher et al.,
2001). We therefore sorted mature Pax5-deficient
(Pax5D/–) B cells as CD25+IgM+ cells from the lymph
nodes of Cd19-cre Pax5fl/– mice and control Pax5D/+ B
cells as CD25IgM+ cells from Cd19-cre Pax5fl/+ mice
(Figure S4A). RT-PCR analysis confirmed complete
Immunity
Pax5-Dependent Gene Activation in B CellsFigure 3. Expression of Pax5-Activated Genes in B Lymphocytes and Other Hematopoietic Lineages
The expression of the indicated genes was analyzed by RT-PCR in different hematopoietic cell types, which were isolated by FACS sorting as shown
in Figure S3. The cDNA input of each sorted cell population was normalized for equal Hprt expression prior to PCR analysis of 5-fold serial cDNA
dilutions.Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 53
Immunity
Pax5-Dependent Gene Activation in B CellsFigure 4. Pax5-Dependent Gene Regulation in Late B Cell Differentiation and Identification of Direct Pax5 Target Genes in Pro-B
Cells
(A) Loss of gene activation upon Pax5 deletion in mature B cells. Control and Pax5-deficient mature B cells were isolated from the lymph nodes of
Cd19-cre Pax5fl/+ mice (abbreviated as Pax5D/+) or Cd19-cre Pax5fl/– (Pax5D/–) mice, respectively (Figure S4A). Both cell types were analyzed for
expression of the indicated genes by RT-PCR. Expression analyses of at least three independent Pax5 deletion experiments yielded the same extent
of transcriptional downregulation for each of the genes shown.
(B) Downregulation of Pax5-activated genes in plasma cells. Bone-marrow cells from nonimmunized IgHgfp/+ mice were sorted as LinGFPhi
CD138hiCD28+ cells (Figure S4B; Delogu et al., 2006) followed by RT-PCR analysis. Mature B cells were sorted as IgM+IgD+ cells from wild-type
lymph nodes. The genes are ranked according to the extent of their downregulation in plasma cells. The analysis of at least three independent plasma
cell preparations yielded similar results for each of the genes shown.
(C) Transcriptional activation of target genes by Pax5-ER. Pax5/ pro-B cells expressing the Pax5-estrogen receptor (ER) fusion protein (KO-Pax5-
ER cells) were treated for 12 hr with 17b-estradiol (E2; 1 mM) prior to RT-PCR analysis of the indicated genes. KO-DPax5-ER cells, expressing a DNA-
binding-deficient Pax5-ER protein, were used as specificity control.
(D) Direct gene activation by Pax5-ER in the absence of protein synthesis. Where indicated, the KO-Pax5-ER cells were preincubated with cyclohex-
imide (CHX; 25 mg/ml) for 30 min prior to the addition of E2 (1 mM) for 6 hr and subsequent RT-PCR analysis. The expression of the same genes in
cultured Pax5+/+ and Pax5/ pro-B cells is shown for comparison.deletion of the floxed Pax5 allele in sorted Pax5D/ B cells,
which consequently expressed the Pax5 target gene
Cd19 at 20% of control Pax5D/+ B cells (Figure 4A;
Horcher et al., 2001). Importantly, the loss of Pax5 led to
a similar or even more pronounced decrease in the
expression of eight additional activated genes analyzed
(Figure 4A). The same genes were also downregulated
upon conditional Pax5 deletion in pro-B cells (Figure 2),
so we conclude that these genes continuously require
Pax5 for their normal expression from the pro-B to the
mature B cell stage.
Under physiological conditions, Pax5 expression is lost
during terminal differentiation to plasma cells (Fuxa and
Busslinger, 2007). To study the expression of Pax5-
activated genes in plasma cells, we took advantage of
a Gfp insertion in the IgH locus, which facilitates
FACS sorting of plasma cells as a pure population of
GFPhiCD138hiCD28+Lin (CD4CD8aF4/80CD21) cells54 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.from the bone marrow of nonimmunized IgHgfp/+ mice
(Delogu et al., 2006; Figure S4B). RT-PCR analysis con-
firmed correct sorting of the plasma cells, because they
expressed high amounts of the Prdm1 transcript coding
for the plasma cell regulator Blimp1, whereas Pax5
mRNA was undetectable (Figure 4B). The loss of Pax5 dif-
ferentially affected expression of the Pax5-activated
genes in plasma cells. Transcription of the genes Cd19,
Spib,Bach2,Cd55, andSiglecgwas dramatically reduced
to %2% in plasma cells compared to mature B cells,
which likely reflects the absence of Pax5 activity in plasma
cells (Figure 4B). The expression of Ikzf3 (Aiolos), Irf8, and
Bcar3 was 5- to 10-fold downregulated in plasma cells. In
contrast, the transcription of Nedd9, Blnk, Cd97, and
Prkd2 was only 2- to 3-fold downregulated, whereas the
expression of Fcrl1 and Atp1b1 was unaffected by the
loss of Pax5 in plasma cells. Moreover, the expression
of Irf4 was even 5-fold increased in plasma cells
Immunity
Pax5-Dependent Gene Activation in B Cells(Figure 4B), as previously reported (Falini et al., 2000).
These latter genes, which are characterized by little or
no expression loss, apparently switch their transcriptional
control during the transition from B cells to plasma cells in
such a way that their Pax5 dependency in B cells is
replaced with the regulation by plasma cell-specific tran-
scription factors. These data therefore indicate that the
transcription of about half of the Pax5-activated genes is
substantially downregulated during terminal plasma cell
differentiation.
Identification of Direct Pax5 Target Genes
The data presented so far do not allow us to distinguish
whether Pax5 activates the newly identified genes directly
or indirectly through induction of the transcriptional
activators shown in Figure 1A. To address this issue, we
studied the kinetics of Pax5-dependent gene activation
by using a posttranslational induction system, which is
based on the hormone-inducible Pax5-estrogen receptor
(ER) fusion protein (Nutt et al., 1998). Pax5/ pro-B cells
expressing the Pax5-ER protein (referred to as KO-Pax5-
ER cells; Nutt et al., 1998) were stimulated with estrogen
(E2) for up to 24 hr, and the transcriptional induction of
selected Pax5-activated genes was analyzed at different
time points by RT-PCR (Figure 4C; Figure S5). Whereas
expression of the repressed Pax5 target gene Igj (J-chain)
was rapidly downregulated (Figure S5), transcription of the
control genesCd19 andBlnkwas induced upon estrogen-
dependent activation of the Pax5-ER protein (Figure 4C;
Figure S5). Similar to Cd19 and Blnk, the transcription of
17 Pax5-activated genes was also induced in estrogen-
stimulated KO-Pax5-ER cells (Figure 4C; Figure S5).
Importantly, the same genes could not be activated by
estrogen treatment in KO-DPax5-ER cells (Figure 4C),
which expressed a DNA-binding-deficient Pax5-ER
protein lacking the paired domain (Nutt et al., 1998).
Hence, the DNA-binding function of Pax5 is essential for
the transcriptional activation of all 17 genes analyzed.
To demonstrate direct gene activation by Pax5, we took
advantage of the fact that the KO-Pax5-ER cells constitu-
tively express the Pax5-ER protein in an inactive form prior
to estrogen stimulation. The Pax5-ER protein can there-
fore be activated by estrogen addition even in the pres-
ence of cycloheximide (CHX), which blocks all protein
synthesis. Under these conditions, the Pax5-ER protein
was still able to induce the transcription of Bcar3, Cd55,
Nedd9, Ikzf3 (Aiolos), Tcf7l2 (TCF4), Irf4, Irf8, Atp1b1,
Ifi30, Vpreb3, and Bach2 within 6 hr of estrogen treatment
(Figure 4D). Hence, the Pax5-ER induction system identi-
fied 11 previously unidentified target genes, which are
directly activated by Pax5 in pro-B cells. The failure to
induce the remaining 6 genes in the presence of cyclohex-
imide is not informative, because it could be caused by
many different reasons such as cylcoheximide-induced
mRNA stabilization (Siglecg) or delayed induction at the
6 hr time point analyzed (Bst1, Tnfrsf19; Figure S5). In-
deed, Siglecg, Bst1, and Tnfrsf19 also proved to be direct
Pax5 target genes, as shown below by other methods.Identification of Putative Regulatory Elements
by Chromatin Profiling of Pax5 Target Genes
Control elements in promoters and enhancers of tran-
scribed genes are present in accessible chromatin
domains, which can be visualized as discrete islands of
histone H3 carrying methylated lysine 4 and acetylated
lysine 9 residues (Bernstein et al., 2005; Kim et al.,
2005). To identify regulatory elements, we therefore local-
ized domains of accessible chromatin by mapping active
histone modifications along Pax5 target genes. For this
purpose, we employed a chromatin immunoprecipita-
tion-coupled DNA microarray analysis (ChIP-on-chip),
which involves immunoprecipitation of active chromatin
from formaldehyde-crosslinked cells followed by mapping
of the precipitated DNA fragments to their corresponding
gene sequences by DNA microarray hybridization (Kim
et al., 2005). We designed a high-density 50-mer oligonu-
cleotide array that contained the nonrepetitive genomic
sequences of selected Pax5-activated and control genes
at 100 base pair resolution. DNA crosslinked to histone
H3 was precipitated from Pax5+/+ and Pax5/ pro-B cells
via modification-specific antibodies that recognized
acetylated lysine 9 (H3K9ac), dimethylated lysine 4
(H3K4me2), or trimethylated lysine 4 (H3K4me3) on his-
tone H3. The precipitated DNA was amplified, fluores-
cently labeled, and hybridized to the above custom micro-
array together with a differently labeled probe consisting
of the input DNA (before precipitation). The hybridization
results of nine Pax5 target genes are shown as relative en-
richment of the individual oligonucleotide sequences in
the precipitated DNA compared to the input probe
(Figure 5A).
ChIP-on-chip analysis of wild-type Pax5+/+ pro-B cells
revealed relatively large clusters of the three active histone
marks H3K9ac, H3K4me2, and H3K4me3 at the pro-
moters and immediate downstream sequences of the
nine Pax5 target genes analyzed (Figure 5A; black trac-
ings). Islands of H3K9ac and H3K4me2 modifications
also colocalized in introns or upstream regions of five of
these genes (Nedd9, Irf8, Bst1, Irf4, and Atp1b1; Fig-
ure 5A). The H3K9ac and H3K4me2 modification patterns
were therefore similar not only at the gene promoters as
published (Bernstein et al., 2005; Kim et al., 2005), but
also coincided in intronic and 50 flanking sequences of
the genes analyzed (Figure 5A). In contrast, enrichment
of the trimethylation mark H3K4me3 was exclusively
found at the 50 end of genes, as previously reported (Bern-
stein et al., 2005). Our data confirmed and extended the
published literature by demonstrating that the modifi-
cation code H3K9ac+ H3K4me2+ H3K4me3+ predicts
gene promoters, whereas the combination H3K9ac+
H3K4me2+ H3K4me3 identifies putative regulatory ele-
ments (likely enhancers) in intronic or intergenic se-
quences of mammalian genes. We next analyzed the
Rag1/2 locus (Figure 5B), which is transcribed in B cells
under the control of the distal Erag element and a proximal
enhancer (Hsu et al., 2003; Wei et al., 2005). The promoter
regions of the Rag1 and Rag2 genes carried the three
modifications H3K9ac, H3K4me2, and H3K4me3,Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 55
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Pax5-Dependent Gene Activation in B CellsFigure 5. Mapping of Active Chromatin Domains in Pax5 Target Genes
(A) Pax5+/+ (+/+) and Pax5/ (/) pro-B cells on a Rag2-deficient background were used for ChIP-on-chip analysis with antibodies that specifically
recognized the acetylated lysine 9 (H3K9ac), dimethylated lysine 4 (H3K4me2), or trimethylated lysine 4 (H3K4me3) on histone H3. Labeled probes
prepared from the precipitated DNA and the input material were hybridized onto a high-density 50-mer oligonucleotide array containing selected
Pax5-activated genes with their flanking sequences at 100 bp resolution (produced by NimbleGen Systems). The logarithmic ratio (log2) of the hy-
bridization intensities between antibody-precipitated and input DNA (bound/input) is shown as a bar for each oligonucleotide on the microarray. Black56 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.
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Pax5-Dependent Gene Activation in B CellsFigure 6. In Vivo Pax5 Binding and
Migration-Adhesion Behavior of Pro-B
Cells
(A) In vitro cultured pro-B cells from the bone
marrow of Pax5+/+ Rag2/ and Pax5/
Rag2/ mice were used for ChIP analysis of
putative regulatory sequences with an affin-
ity-purified polyclonal antibody recognizing
the Pax5 paired domain. The immunoprecipi-
tated (IP) DNA and 5-fold serial dilutions of
the input chromatin (1/100) were analyzed by
PCR for enrichment of the putative regulatory
sequences. The positions of the amplicons
analyzed are indicated by red arrows in
Figure 5A. Analyses of the tubulin (Tub)
promoter and Pax5/ Rag2/ pro-B cells
served as negative controls.
(B) Transfilter migration assay. Pax5+/+ or
Pax5/ pro-B cells in IL-7-containing RPMI
1640 medium were placed in the upper com-
partment, whereas IL-7 medium containing
400 ng/ml CXCL12 (SDF-1a; Sigma) was pres-
ent in the lower compartment of a transwell
chamber separated by a filter of 5 mm pore
size. Pro-B cells migrating into the lower cham-
ber were measured after 2 hr by flow cytometry
and are indicated as percentage of the total
cells. The average percentage and standard
deviation of three independent experiments
are shown.
(C) Adhesion assay. Pax5+/+ or Pax5/ pro-B cells were allowed to adhere to VCAM1-Fc-coated glass coverslips for 14 hr in IL-7-containing IMDM
medium, washed twice, and fixed in 4% paraformaldehyde, followed by additional washes and staining with Alexa568-phalloidin (see Supplemental
Experimental Procedures). Six coverslips were evaluated for each pro-B cell type by automatic cell counting in a fluorescence microscope. The
average cell density and standard deviation is shown for one of three representative experiments.whereas the Erag and proximal enhancers were charac-
terized by the two active marks H3K9ac and H3K4me2
in the absence of H3K4me3 (Figure 5B). The analysis of
theRag1/2 locus therefore confirmed the predictive power
of the identified histone modification codes for defining
promoters and enhancers.
Pax5 Activates Its Target Genes by Binding
to Promoters and Putative Enhancers
Chromatin profiling of the Pax5/ pro-B cells demon-
strated that the histone modification profile of Pax5 target
genes was altered in the absence of Pax5 (Figure 5A; red
tracings). Four distinct patterns of chromatin changes
were observed. First, the active histone marks H3K9ac,
H3K4me2, and H3K4m3 were strongly reduced or entirely
absent at the 50 region (promoter) of the four genes Blnk,
Siglecg, Irf4, and Atp1b1 in Pax5/ pro-B cells
(Figure 5A). Second, the promoter regions of the Tnfrsf19
and Vpreb3 genes contained substantially less H3K9ac
and H3K4m3 modifications in Pax5/ pro-B cells com-
pared to Pax5+/+ pro-B cells, although the abundance of
the H3K4me2 mark was similar in both pro-B cell types(Figure 5A). Third, H3K9ac and H3K4me2 islands were
missing at the putative enhancers of Nedd9 and Irf8,
whereas their promoters exhibited similar patterns of all
three active chromatin marks (Figure 5A). Finally, all active
histone modifications were lost at both the promoter and
putative enhancer of the Bst1 gene in Pax5/ pro-B cells
(Figure 5A). Together, these data indicate that Pax5 is
essential for the formation of active chromatin domains
at promoters and/or putative enhancers of Pax5 target
genes.
To demonstrate direct binding of Pax5 to regions of
Pax5-dependent chromatin, we used Pax5+/+ Rag2/
pro-B cells for ChIP experiments with a polyclonal Pax5
antibody (Figure 6A). The same ChIP analysis was per-
formed also with Pax5/ Rag2/ pro-B cells to control
for the specificity of the Pax5 antibody (Figure 6A). The
PCR primers were designed to amplify a DNA fragment
(indicated by a red arrow in Figure 5A) that contained a
predicted Pax5-binding site located within the Pax5-
dependent chromatin region. These ChIP analyses un-
equivocally demonstrated that the DNA sequences corre-
sponding to Pax5-dependent chromatin domains of the(Pax5+/+) and red (Pax5/) colors indicate the histone modification patterns of wild-type andPax5mutant pro-B cells, respectively. The results shown
are representative of two ChIP-on-chip experiments, which were performed with independently prepared samples of Pax5+/+ Rag2/ and Pax5/
Rag2/ pro-B cells. The exons and introns of each gene are shown by black and open boxes, respectively. Black arrows indicate the 50 end of the
genes, and red arrows denote the location of the amplicons, which were analyzed in the Pax5 antibody ChIP experiment shown in Figure 6A.
(B) Mapping of active histone modifications along the Rag1/2 locus in Pax5+/+ Rag2/ pro-B cells (+/+).Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 57
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Rag2/ pro-B cells relative to the background signals ob-
tained with Pax5/ Rag2/ pro-B cells (Figure 6A). We
therefore conclude that direct binding of Pax5 to pro-
moters or putative enhancers leads to the formation of ac-
tive chromatin domains and subsequent activation of
Pax5 target genes.
Pax5-Dependent Control of B Lymphocyte Migration
and Adhesion
Six Pax5-activated genes (Bst1,Cd44,Cd55, Cd97, Sdc4,
and Tnfrsf19) code for cell-surface molecules and nine
genes (Bcar3, Capn2, Eps8, Fhod3, Gsn, Myh10, Mylip,
Nedd9, and Pard3) code for intracellular proteins, which
have been implicated in cell migration and adhesion (see
Discussion). Hence, we experimentally verified the hy-
pothesis that Pax5 controls the migration and adhesion
behavior of B lymphocytes. In a transwell migration assay,
Pax5/ pro-B cells showed a 4-fold increased migration
toward a source of the chemokine CXCL12 (SDF-1a) in
comparison to Pax5+/+ pro-B cells (Figure 6B). By con-
trast, the Pax5+/+ pro-B cells in the presence of CXCL12
adhered 32 times better than Pax5/ pro-B cells to a
surface, which was coated with VCAM-1, the ligand for
the integrin VLA-4 (Figure 6C). These differences were,
however, not caused by differential expression of the
CXCL12 receptor CXCR4 or the integrin VLA-4 in the
two pro-B cell types (data not shown). In summary, we
conclude that Pax5 regulates the adhesion and migration
properties of B lymphocytes. The observed inverse rela-
tionship between cell migration and adhesion is consistent
with the general notion that slowly moving cells exhibit
stronger substrate adhesion relative to faster migrating
cells (Kaverina et al., 2002).
DISCUSSION
Pax5 executes its B cell commitment function by activat-
ing B lymphoid-specific genes and simultaneously repres-
sing B lineage-inappropriate genes, which we recently
characterized in detail (Delogu et al., 2006). Here we
have identified 170 Pax5-activated genes, of which 66
genes were further validated to be expressed under
Pax5 control. These Pax5-regulated genes have provided
important insight into the activation function of Pax5, be-
cause they code for key regulatory and effector proteins
involved in diverse biological processes as discussed be-
low.
Our cDNA microarray analysis uncovered an important
role of Pax5 in the control of B cell adhesion and migration
by regulating the expression of cell-surface receptors and
intracellular signal transducers leading to remodeling of
the actin cytoskeleton. Six Pax5-activated genes, Bst1,
Cd44, Sdc4, Tnfrsf19,Cd97, andCd55, code for adhesion
receptors on B lymphocytes (Figure 7A). Bst1 (CD157) is
required for normal antibody responses and B1 cell devel-
opment (Itoh et al., 1998) as well as for leukocyte adhesion58 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.and migration (Funaro et al., 2004). CD44 mediates lym-
phocyte recirculation (Protin et al., 1999), whereas activa-
tion of syndecan-4 (Sdc4) induces filapodia formation in B
cells (Yamashita et al., 1999). Tnfrsf19 (Troy, Taj) likely
controls actin filament dynamics in early B cell develop-
ment in analogy to its inhibitory function as part of the
Nogo receptor in nerve fiber regeneration (Mandemakers
and Barres, 2005). CD97 has been implicated in the migra-
tion of leukocytes to sites of inflammation and can be ac-
tivated by one of the three ligands chondroitin sulfate, in-
tegrin VLA-5, and CD55 (Leemans et al., 2004). In addition
to its role as CD97 ligand, CD55 (Daf1) also protects host
cells from complement-mediated attack (Longhi et al.,
2006).
Integrin-linked focal adhesion complexes provide the
primary sites of cell adhesion to extracellular matrix and
associate with the actin cytoskeleton to control cell move-
ments (Figure 7B). Integrin clustering leads to autophos-
phorylation of the focal adhesion kinase (FAK), which sub-
sequently recruits additional proteins into the focal
adhesion complex (Figure 7B). Signals emanating from
this complex activate the GTPases Rho, Rac, and
Cdc42, which induce actin rearrangements leading to
the assembly of contractile actin-myosin filaments at the
rear of the cell (Rho) as well as to protrusive actin-rich la-
mellipodia (Rac) and filopodia (Cdc42) at the leading edge
of the cell (Jaffe and Hall, 2005). Nine Pax5-regulated
genes (Nedd9, Bcar3, Capn2, Eps8, Gsn, Pard3, Fhod3,
Myh10, and Mylip) code for intracellular proteins involved
in cell adhesion and migration (Figure 7B). The adaptor
protein Nedd9 (Hef1, Cas-L) is required for lymphocyte
trafficking, adhesion, and chemotactic responses of follic-
ular B cells as well as for the generation of marginal zone B
cells in the spleen (Seo et al., 2005). Nedd9 likely mediates
its effect on cell adhesion through its partner protein Bcar3
(AND-34), a guanine nucleotide exchange factor (GEF;
Gotoh et al., 2000), which activates the GTPase Cdc42
in B cells, leading to actin polymerization and filopodia for-
mation (Cai et al., 2003). The cysteine protease calpain-2
(Capn2) is an essential regulator of cell movement,
because it triggers, upon phosphorylation by MAP kinase,
the disassembly of focal adhesion structures by cleaving
multiple adhesion components (Huttenlocher et al.,
1997). The Eps8 protein is phosphorylated in response
to receptor tyrosine kinase signaling and is then integrated
into the trimeric Eps8-Abi1-Sos1 complex, which pos-
sesses Rac-specific GEF activity and thus links Ras
signaling to Rac activation, resulting in actin remodeling
(Innocenti et al., 2002). Eps8 also influences actin-based
motility by its second, actin barbed-end-capping activity
(Disanza et al., 2004). Gelsolin (Gsn) contributes to leuko-
cyte migration by severing actin filaments and capping the
newly formed barbed ends (Witke et al., 1995). Fhos2
(Fhod3) is a new member of the actin-polymerizing formin
protein family (Kanaya et al., 2005). The Par3 (Pard3) pro-
tein associates with Par6 and atypical PKC in a complex
that is activated by GTP-bound Cdc42. Par3 has been
implicated in actin turnover during cell polarization by con-
trolling the filament-severing activity of cofilin through
Immunity
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Cell Adhesion and Migration
(A) Adhesion and chemokine receptors, which
are expressed under the control of Pax5 in B
lymphocytes. Bst1 and CD55 are GPI-linked
proteins. Alternative protein names: Tnfrsf19
(Troy, Taj); Bst1 (CD157, BP-3); CD55 (Daf1);
Edg1 (S1P1).
(B) Schematic diagram of the signaling path-
ways from integrins and growth factor recep-
tors to the actin cytoskeleton. The proteins
encoded by Pax5-activated genes are high-
lighted in green. Alternative protein names:
Bcar3 (AND-34, NSP2); Fhos2 (Fhod3); myosin
heavy chain IIB (Myh10); MIR (Mylip); Nedd9
(Hef1, Cas-L); Par3 (Pard3).inhibition of the LIM kinase 2 (Chen and Macara, 2006).
The myosin heavy-chain isoform IIB (Myh10) is required,
as part of the contractile stress fibers, for directional
movement of fibroblasts (Lo et al., 2004), suggesting
a similar role for the Pax5-controlled myosin IIB protein
in B cell migration. The motor activity and filament associ-
ation of myosin II is controlled by phosphorylation of the
myosin regulatory light chain (MRLC). The MRLC-interact-
ing protein MIR (Mylip) functions as an ubiquitin E3 ligase
to control the proteasome-mediated turnover of the phos-
phorylated MRLC, which is essential for cell migration (Na-
gano et al., 2006). Finally, lymphocyte trafficking is also
controlled by the sphingosine-1-phosphate receptor 1
(S1P1), a G protein-coupled receptor encoded by the
Pax5-activated gene Edg1 (Figure 7A). B cells lacking
the S1P1 receptor fail to localize to the marginal zone
and are sequestered in lymphoid organs as they are un-
able to recirculate through the blood to other organs in
response to the chemokine sphingosine-1-phosphate(Cinamon et al., 2004). Pax5 likely regulates the Edg1
gene indirectly by activating the expression of the tran-
scription factor Klf2, a known regulator of Edg1 expres-
sion (Carlson et al., 2006). In summary, our analysis has
identified Pax5 as a key regulator of B cell adhesion and
migration, consistent with the finding that Pax5+/+ and
Pax5/ pro-B cells differ in their adhesion and migration
properties.
Pax5 has been implicated in the control of (pre)BCR sig-
naling by the previously characterized Pax5 target genes
Cd19, Cr2 (CD21), Cd72, Cd79a (Iga), and Blnk (Nutt
et al., 1998; Horcher et al., 2001; Schebesta et al.,
2002). The identification of the Pax5-activated genes
Vpreb3, Igk, Slamf6, Siglecg, Lcp2, Plekha2, Prkd2,
Ikzf2, and Spib2 has now extended the notion that Pax5
controls signaling from the (pre)BCR on the cell surface
to transcription in the nucleus at multiple levels. The surro-
gate light-chain VpreB3 and conventional light-chain Igk
are essential components of the pre-BCR and BCR,Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc. 59
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regulates B cell tolerance by fine-tuning BCR signaling in
immature B lymphocytes (Kumar et al., 2006). Siglec-G
functions as an inhibitory coreceptor of BCR signaling in
B1 cells (Hoffmann et al., 2007) similar to CD72 in B2 cells.
SLP-75 (Lcp2) together with the related adaptor protein
BLNK (SLP-65) links pre-BCR-mediated activation of
Syk to PLCg and calcium signaling (Su and Jumaa,
2003). The adaptor protein TAPP2 (Plekha2) also signals,
in a PI3K-dependent manner, increased calcium mobiliza-
tion and actin reorganization in response to BCR cross-
linking (Allam and Marshall, 2005). Activation of the protein
kinase PKD2 (Prkd2) by diacylglycerol (DAG) and protein
kinase C3 (Rozengurt et al., 2005) links BCR signaling to
chromatin control by regulating class II histone deacety-
lases (Matthews et al., 2006). Finally, the transcription
factors Aiolos (Ikzf3) and Spi-B (Spib) control the threshold
of BCR signaling in an opposite manner, as B cell pro-
liferation and immune responses are augmented in the
absence of Aiolos (Wang et al., 1998), whereas Spib
mutant B lymphocytes exhibit reduced antigen-depen-
dent proliferation and survival (Su et al., 1997). The com-
bined loss of these signaling molecules likely explains
the failure of mature B cells to proliferate upon conditional
Pax5 inactivation (Horcher et al., 2001).
Pax5 controls the expression of four regulators
(Tnfrsf13c, Prkcb1, T2bp, and Pea15) of the NF-kB path-
way, which enhances B cell survival by activating antia-
poptotic genes in response to stimulation of the BCR or
TNF receptor family members. The viability of peripheral
B cells critically depends on signaling of the BAFF recep-
tor (Tnfrsf13c; Shulga-Morskaya et al., 2004). The protein
kinase Cb (Prkcb1) links BCR crosslinking to NF-kB acti-
vation by regulating the a subunit of the IkB kinase (Saijo
et al., 2002). The Traf-interacting protein T2bp also acti-
vates the IkB kinase by promoting the polymerization
and ubiquitination of the upstream adaptor TRAF6 likely
in response to CD40 signaling in B cells (Ea et al., 2004).
Finally, the death effector domain-containing protein
Pea15 antagonizes Fas- and TNFR1-mediated apoptosis
(Condorelli et al., 1999). The downregulation of these cell
survival-promoting molecules likely contributes to the
observed loss of mature B cells after conditional Pax5
mutation (Horcher et al., 2001).
The antigen-driven development of germinal-center
(GC) B cells depends on signaling of the receptors
CD19, CD21, and CD40, which are expressed under
Pax5 control in mature B cells (Horcher et al., 2001).
Pax5 also regulates the expression of the transcription
factors Bach2, Aiolos (Ikzf3), IRF-4, and IRF-8, which
control different aspects of the GC B cell transcription pro-
gram (Muto et al., 2004; Wang et al., 1998; Klein et al.,
2006; Lee et al., 2006; Nera et al., 2006). These findings
likely account for the observed reduction of serum IgG
titers in Cd19-cre Pax5fl/ mice (Horcher et al., 2001). B
cells also participate in immune reactions by presenting
antigenic peptides on major histocompatibity complex
(MHC) class II molecules to CD4+ helper T cells. The
MHC class II locus codes for classical H2-A and H2-B60 Immunity 27, 49–63, July 2007 ª2007 Elsevier Inc.and nonclassical H2-M and H2-O molecules. Pax5
controls the antigen-presentation function of B cells by
regulating the genes H2-Ob, Ifi30, and C2ta. Upon BCR-
mediated internalization, exogenous antigens are cleaved
into peptides in the proteolytic environment of lysosomes
and are then loaded onto MHC class II molecules with the
help of the lysosomal protein H2-M. The B cell-specific
H2-O molecule restricts the activity of H2-M to lysosomes
by binding and inactivating H2-M in the endosomal com-
partments (Liljedahl et al., 1998). The lysosomal thiol
reductase GILT (Ifi30) cleaves disulfide bonds and thus fa-
cilitates complete antigen processing and presentation of
disulfide-bonded proteins (Maric et al., 2001). Finally, the
transcriptional coactivator CIITA is a master regulator of
classical MHC class II genes, and its loss upon conditional
Pax5 inactivation explains the previously described down-
regulation of MHC class II molecules on Pax5-deficient B
cells (Horcher et al., 2001; Mikkola et al., 2002).
Transcription factors control gene expression by modu-
lating the chromatin structure of their target genes. By
using the posttranslational Pax5-ER induction system, we
have so far identified a dozen of the newly identified genes
as direct targets of Pax5. Chromatin profiling of these genes
by ChIP-on-chip analysis of wild-type pro-B cells identified
islands of active histone marks at their promoters and
putative regulatory elements (likely enhancers) in intronic
or intergenic regions, which were characterized by the
distinct histone modification codes H3K9ac+ H3K4me2+
H3K4me3+ (promoters) and H3K9ac+ H3K4me2+
H3K4me3 (enhancers), respectively. Active chromatin
islands were, however, absent at either the promoter
or putative enhancer region of Pax5 target genes in
Pax5/ pro-B cells. Direct binding of Pax5 to these
Pax5-dependent chromatin regions in wild-type pro-B
cells revealed a critical role for this transcription factor
in establishing active chromatin at promoters or en-
hancers of its target genes. The chromatin-modifying
activity of Pax5 may be partly explained by its interac-
tion with histone acetyltransferases such as the coac-
tivator CBP or the SAGA complex (Emelyanov et al.,
2002; Barlev et al., 2003). Whether Pax5 also recruits
other histone-modifying enzymes such as the H3K4-
methylating Trithorax complex remains an interesting
possibility to be addressed by future investigations.
EXPERIMENTAL PROCEDURES
Detailed methods can be found in the Supplemental Data online.
Mice
Pax5+/, Pax5fl/fl, Rag2/, IgHgfp/+, Cd19cre/cre, and CreED-30 mice
were maintained on the C57BL/6 background. Heterozygous
Cd19cre/+ mice are referred to as Cd19-cre mice in this manuscript.
All animal experiments were carried out according to valid project li-
censes, which were approved and regularly controlled by the Austrian
Veterinary Authorities.
Pro-B Cell Culture
Pro-B cells were cultured on g-irradiated ST2 cells in IL-7 containing
IMDM medium as described (Nutt et al., 1997).
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The following two cDNA microarrays corresponding to18,000 differ-
ent UniGene clusters were analyzed: one microarray consisted of
19,600 random mouse ESTs, and the mouse ‘‘lymphochip’’ con-
tained 18,000 cDNAs enriched for B and T cell-specific genes
(Shaffer et al., 2004). The two microarrays were hybridized with Cy3-
and Cy5-labeled probes prepared from the different Pax5+/+ and
Pax5/ pro-B cell pairs. The data of the hybridized microarrays
were scanned to determine the Cy3/Cy5 fluorescence value (activation
ratio) of the individual cDNA spots. Only cDNA clones with an at least
2-fold activation ratio in all hybridizations were listed as Pax5-acti-
vated genes in Table S3.
Semiquantitative RT-PCR Analysis
cDNA was prepared from ex vivo sorted or in vitro cultured hematopoi-
etic cell types and analyzed by semiquantitative PCR (Delogu et al.,
2006) via the primers listed in Table S1.
Conditional Pax5 Inactivation in Pro-B Cells
Cultured pro-B cells from CreED-30 Pax5fl/fl mice were treated with 1
mM 4-hydroxytamoxifen (OHT), and RNA was prepared at daily inter-
vals followed by semiquantitative RT-PCR analysis (Mikkola et al.,
2002).
Conditional Pax5 Activation in Pro-B Cells
Pax5/ pro-B cells expressing the Pax5-ER protein (KO-Pax5-ER
cells) or the DNA-binding-deficient DPax5-ER protein (KO-DPax5-ER
cells; Nutt et al., 1998) were treated with 1 mM 17b-estradiol (E2) and
25 mg/ml cycloheximide (CHX, where indicated). RNA was isolated at
different time points and subjected to semiquantitative RT-PCR
analysis.
FACS Sorting
Antibodies were purchased from PharMingen. The following cell types
were isolated from wild-type mice by double sorting as shown in Fig-
ure S3: pro-B (LinCD19+c-Kit+), pre-B (LinCD19+CD25+IgM), im-
mature B (LinCD19+IgM+IgD), mature B cells (LinCD19+IgMloIgDhi),
granulocytes (LinMac1+Gr1+), erythroblast (c-Kit+Terr119+), and thy-
mocytes (LinThy1.2+CD19). Pax5/ pro-B cells were twice sorted
as LinB220+c-Kit+ cells from 2-week-old Pax5 mutant mice (Fig-
ure S1B), mature Pax5-deficient B cells as LinCD25+IgM+ B cells
from 8-week-old Cd19-cre Pax5fl/ mice (Figure S4A), and plasma
cells as LinGFPhiCD138hiCD28+ cells from R10-week-old IgHgfp/+
mice (Figure S4B; Delogu et al., 2006).
Chromatin Immunoprecipitation
Pax5+/+ Rag2/ and Pax5/ Rag2/ pro-B cells were cultured
in vitro prior to chromatin immunoprecipitation (ChIP) according to
the Upstate Biotechnology protocol. ChIP analyses were performed
with an affinity-purified polyclonal rabbit antibody directed against
the Pax5 paired domain as well as with purified antibodies (Upstate
Biotechnology Inc.) recognizing the histone modifications H3K9ac
(07-352), H3K4 me2 (07-030), and H3K4 me3 (07-473). The precipi-
tated DNA was quantified by PCR with the primers shown in Table S2.
ChIP-on-Chip Analysis
Genomic DNA prepared from chromatin-immunoprecipitated material
and sheared input chromatin was subjected to T7-based linear ampli-
fication as described (Liu et al., 2003). The amplified DNA was quality
controlled, quantified, and sent to NimbleGen Systems for probe prep-
aration and hybridization to a custom-made 50-mer oligonucleotide
microarray, which contained the nonrepetitive genomic sequences
of selected Pax5-activated genes at 100 bp resolution.
Supplemental Data
Five figures, four tables, and Experimental Procedures are available at
http://www.immunity.com/cgi/content/full/27/1/49/DC1/.ACKNOWLEDGMENTS
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